98%
921
2 minutes
20
We assessed the response of primary cultures of placental villous mononucleated trophoblasts and multinucleated syncytiotrophoblast to calcitriol, the most biologically active form of vitamin D. Whole-genome microarray data showed that calcitriol modulates the expression of many genes in trophoblasts within 6 hours of exposure and RT-qPCR revealed similar responses in cytotrophoblasts, syncytiotrophoblasts and villous explants. Both cytotrophoblasts and syncytiotrophoblasts expressed genes for the vitamin D receptor, for LRP2 and CUBN that mediate internalization of calcidiol, for that encodes the enzyme that converts calcidiol into active calcitriol, and for that encodes the enzyme that modifies calcitriol and calcidiol to inactive calcitetrol. Notably, we found an inverse effect of calcitriol on expression of CD14 and CD180/RP105, proteins that differentially regulate toll-like receptor 4-mediated immune responses. Supported by gene ontology analysis, we tested the hypothesis that CD14 and CD180 modulate the inflammatory response of syncytiotrophoblast to bacterial lipopolysaccharide (LPS). These cells showed a robust response to a wide range of LPS concentrations, with induction of active NF-κB and increased secretion of IL-6 and IL-8. SiRNA-mediated knockdown of reduced the secretion of IL-6 and IL-8 in response to LPS. Collectively, our data showed that calcitriol has a rapid and widespread effect on villous trophoblast gene expression in general, and a specific effect on the innate immune response by syncytiotrophoblast.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1530/REP-17-0183 | DOI Listing |
Medicine (Baltimore)
August 2025
University of Health Sciences Turkey, Konya City Hospital, Clinic of Pathology, Konya, Turkey.
Breast cancer is a heterogeneous disease in which estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 play crucial roles in molecular subtyping, diagnosis, treatment, and prognosis, showing positivity in nearly 90% of cases. The vitamin D receptor (VDR) has been implicated in the oncogenesis and prognosis of various tumors, but its relationship with molecular subtyping factors in breast carcinomas remains to be clarified. This retrospective cross-sectional study included 111 patients who underwent surgery for breast carcinoma.
View Article and Find Full Text PDFEndocr Pract
August 2025
Endocrinology, Columbia University, New York, NY, USA.
Objective: To examine the impact of palopegteriparatide (YORVIPATH®; TransCon® PTH) on real-world clinical outcomes in adult patients with hypoparathyroidism.
Methods: Adult patients with hypoparathyroidism who enrolled in the US expanded access program (EAP) as of October 2024 and provided consent were included in the analysis. Palopegteriparatide was administered at a recommended starting dose of 18 μg/day and titrated alongside conventional therapy (calcitriol and calcium).
JBMR Plus
September 2025
Department of Endocrinology, The Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.
McCune-Albright syndrome (MAS) is a rare mosaic genetic disorder caused by a mutation in the gene and typically presents with a triad of symptoms: fibrous dysplasia of bones, café-au-lait macules, and precocious puberty. The mutation leads to overproduction of fibroblast growth factor-23 (FGF23), which may result in hypophosphatemia. Burosumab, a monoclonal antibody against FGF23, is approved for the treatment X-linked hypophosphatemia and tumor-induced osteomalacia.
View Article and Find Full Text PDFInt J Mol Sci
July 2025
Beijing Key Laboratory of Sports Performance and Skill Assessment, Beijing Sport University, Beijing 100084, China.
Recent breakthroughs in cancer immunotherapy have shown remarkable success, yet treatment efficacy varies significantly among individuals. Emerging evidence highlights the gut microbiota as a key modulator of immunotherapy response, while vitamin D (VD), an immunomodulatory hormone, has garnered increasing attention for its potential interactions with gut microbiota and immunotherapy outcomes. However, the precise mechanisms and clinical applications of VD in this context remain controversial.
View Article and Find Full Text PDFPathol Res Pract
October 2025
Department of Abdominal Oncology, Jilin Cancer Hospital, Changchun 130000, China. Electronic address:
Background: Gastrointestinal cancers (GICs), encompassing malignancies of the esophagus, stomach, and colorectal regions, are among the most prevalent cancers worldwide. Given the inconsistent and heterogeneous findings across studies, this meta-analysis aims to comprehensively assess the association between vitamin D receptor (VDR) gene polymorphisms and the risk of GICs.
Methods: A systematic search was conducted in MEDLINE, Web of Science, Scopus, and Embase to identify relevant studies investigating the association between VDR polymorphisms and GIC risk.